ReviewDer Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft2010
[Operative techniques for surgical treatment of primary and recurrent pterygia].
Review in Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.
- Pooled it
- [Modified mini-SLET for treatment of complex cases in pterygium surgery].Die Ophthalmologie · 2024Article
- Evaluation of the Efficacy of Different Pterygium Surgeries in Polish Caucasian Population.Journal of ophthalmology · 2022Article
- [Pterygium and pinguecula].Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft · 2021Article
- [Pterygium: what about point of care biomarkers?]Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft · 2021Article
- [Pterygium: pathogenesis, diagnosis and treatment].Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft · 2021Article
- Overexpression of fractalkine and its histopathological characteristics in primary pterygium.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2019Article
- Clinical analysis of risk factors contributing to recurrence of pterygium after excision and graft surgery.International journal of ophthalmology · 2015Article
- Expression of cell proliferation and apoptosis biomarkers in pterygia and normal conjunctiva.Molecular vision · 2011Article
- [Pterygium. Etiology, clinical aspects and novel adjuvant therapies].Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft · 2010Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Surgical treatment of pterygia is indicated when there is a reduction of visual acuity secondary to the development of irregular astigmatism and an (impending) obscuration of the visual axis by the tumor. Poor cosmetic appearance and an insufficient corneal lubrication are more rare indications. The most popular surgical technique in this country appears to be a free conjunctival autograft which, depending on the priority of the surgeon, is combined with adjunctive antimetabolite therapy applied either in primary or recurrent cases. A simultaneous transplantation of conjunctival and limbal stem cell autografts is an excellent method to be considered particularly in cases of recurrent pterygia. In the case of non-existing healthy autologous tissue the resection bed can be covered by preserved amniotic membrane. A lamellar sectorial corneal graft might become necessary if there is a deep corneal defect. The well established technique of suturing the graft has been replaced by fibrin glue in some surgical centers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.